ET(A) receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat

Journal of the American Society of Nephrology

Volumn 8, Issue 7, 1997, Pages 1054-1060

  Pollock, David M ^a,b   Polakowski, James S ^a  

^a ABBOTT LABORATORIES   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (N,N DIBUTYLACETAMIDO) 4 (1,3 BENZODIOXOL 5 YL) 2 (4 METHOXYPHENYL)PYRROLIDINE 3 CARBOXYLIC ACID; ATRASENTAN; BIG ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; PROTEIN PRECURSOR; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION; ANIMAL; CHRONIC KIDNEY FAILURE; DISEASE MODEL; DRUG ANTAGONISM; KIDNEY; NEPHRECTOMY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTHELINS; HYPERTENSION, RENAL; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; PROTEIN PRECURSORS; PROTEINURIA; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0030610178     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Deen WM, Maddox DA, Robertson CR, Brenner BM: Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol 227: 556-562, 1974
2. Hayslett JP: Functional adaptation to reduction in renal mass. Physiol Rev 59: 137-164, 1979
3. Hosteller TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241: F85-F93, 1981
4. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985
5. Jackson B, Johnson CI: The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: Effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 6: 495-501, 1988
6. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992
7. Pelayo JC, Quan AH, Shanley PF: Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am J Physiol 258: F414-F422, 1990
8. Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ: Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 267: 657-663, 1993
9. Benigni A, Pericao N, Gaspari F, Zoja C, Bellizzi L, Gabanelli M, Remuzzi G: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 260: F331-F339, 1991
10. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43: 354-358, 1993
11. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44: 440-444, 1993
12. Torralbo A, Trobo JI, Borque M, Herrero JA, Velasco E, Marcello M, González-Mate A, Barrientos A: Alterations in renal endothelin production in rats with reduced renal mass. Am J Kidney Dis 25: 918-923, 1995
13. Brooks DP, Contino LC, Storer B, Ohlstein EH: Increased endothelin excretion in rats with renal failure induced by partial nephrectomy. Br J Pharmacol 104: 987-989, 1991
14. A-selective receptor antagonist. J Pharmacol Exp Ther 276: 473-481, 1996
15. Benigni A, Zoja C, Corna D, Orisio S, Facchinetti D, Benatti L, Remuzzi G: Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am J Kidney Dis 27: 416-423, 1996
16. 125I]IRL-1620, a potent agonist specific for endothelin-B receptors. J Pharmacol Exp Ther 268: 202-207, 1994
17. A receptor activation. Am J Physiol 264: R222-R226, 1993
18. A receptor antagonist, BQ-123, on pressor responses to endothelin family peptides. Endothelium 1: 55-59, 1993